NOTCH2 and breast adenocarcinoma: Accordingly, a recent study demonstrates that activation of different Notch receptors in the human mammary adenocarcinoma cell line MDA-MB-231 drives dramatically opposing effects, leading to either increased apoptosis in the case of Notch2 or increased proliferation in the case of Notch4 [35].